A randomized, open label study to determine the relative bioavailability of inhaled indacaterol given with and without oral activated charcoal for two formulations of indacaterol- lactose blend formulation and Pulmosphere based formulation in healthy adult subjects.

Trial Profile

A randomized, open label study to determine the relative bioavailability of inhaled indacaterol given with and without oral activated charcoal for two formulations of indacaterol- lactose blend formulation and Pulmosphere based formulation in healthy adult subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Indacaterol (Primary) ; Charcoal
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Pharmacogenomic; Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 25 Feb 2013 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India record.
    • 14 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top